These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
546 related items for PubMed ID: 18162396
1. Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies. Temperini C, Cecchi A, Boyle NA, Scozzafava A, Cabeza JE, Wentworth P, Blackburn GM, Supuran CT. Bioorg Med Chem Lett; 2008 Feb 01; 18(3):999-1005. PubMed ID: 18162396 [Abstract] [Full Text] [Related]
2. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies. Güzel O, Temperini C, Innocenti A, Scozzafava A, Salman A, Supuran CT. Bioorg Med Chem Lett; 2008 Jan 01; 18(1):152-8. PubMed ID: 18024029 [Abstract] [Full Text] [Related]
3. Carbonic anhydrase inhibitors. Interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: kinetic and X-ray crystallographic studies. Temperini C, Innocenti A, Mastrolorenzo A, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2007 Sep 01; 17(17):4866-72. PubMed ID: 17588751 [Abstract] [Full Text] [Related]
4. Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV). Innocenti A, Vullo D, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2008 Mar 01; 18(5):1583-7. PubMed ID: 18242985 [Abstract] [Full Text] [Related]
5. Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct. Temperini C, Cecchi A, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2008 Apr 15; 18(8):2567-73. PubMed ID: 18374572 [Abstract] [Full Text] [Related]
6. Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited--old leads for new applications? Temperini C, Cecchi A, Scozzafava A, Supuran CT. Org Biomol Chem; 2008 Jul 21; 6(14):2499-506. PubMed ID: 18600270 [Abstract] [Full Text] [Related]
7. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies. Carta F, Garaj V, Maresca A, Wagner J, Avvaru BS, Robbins AH, Scozzafava A, McKenna R, Supuran CT. Bioorg Med Chem; 2011 May 15; 19(10):3105-19. PubMed ID: 21515057 [Abstract] [Full Text] [Related]
8. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib. Di Fiore A, Pedone C, D'Ambrosio K, Scozzafava A, De Simone G, Supuran CT. Bioorg Med Chem Lett; 2006 Jan 15; 16(2):437-42. PubMed ID: 16290146 [Abstract] [Full Text] [Related]
9. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides. Güzel O, Innocenti A, Scozzafava A, Salman A, Parkkila S, Hilvo M, Supuran CT. Bioorg Med Chem; 2008 Oct 15; 16(20):9113-20. PubMed ID: 18819811 [Abstract] [Full Text] [Related]
10. Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II. Menchise V, De Simone G, Di Fiore A, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2006 Dec 15; 16(24):6204-8. PubMed ID: 17000110 [Abstract] [Full Text] [Related]
11. Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-ray crystallographic studies. Temperini C, Innocenti A, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2008 Aug 01; 18(15):4282-6. PubMed ID: 18640037 [Abstract] [Full Text] [Related]
12. Designing of novel carbonic anhydrase inhibitors and activators. Supuran CT, Vullo D, Manole G, Casini A, Scozzafava A. Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan 01; 2(1):49-68. PubMed ID: 15328829 [Abstract] [Full Text] [Related]
13. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides. Saczewski F, Innocenti A, Sławiński J, Kornicka A, Brzozowski Z, Pomarnacka E, Scozzafava A, Temperini C, Supuran CT. Bioorg Med Chem; 2008 Apr 01; 16(7):3933-40. PubMed ID: 18242998 [Abstract] [Full Text] [Related]
14. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases. Lopez M, Paul B, Hofmann A, Morizzi J, Wu QK, Charman SA, Innocenti A, Vullo D, Supuran CT, Poulsen SA. J Med Chem; 2009 Oct 22; 52(20):6421-32. PubMed ID: 19827837 [Abstract] [Full Text] [Related]
15. Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference. Temperini C, Cecchi A, Scozzafava A, Supuran CT. Bioorg Med Chem; 2009 Feb 01; 17(3):1214-21. PubMed ID: 19119014 [Abstract] [Full Text] [Related]
16. Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV. Smaine FZ, Pacchiano F, Rami M, Barragan-Montero V, Vullo D, Scozzafava A, Winum JY, Supuran CT. Bioorg Med Chem Lett; 2008 Dec 15; 18(24):6332-5. PubMed ID: 18990571 [Abstract] [Full Text] [Related]
17. Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design. Temperini C, Scozzafava A, Vullo D, Supuran CT. J Med Chem; 2006 May 18; 49(10):3019-27. PubMed ID: 16686544 [Abstract] [Full Text] [Related]
18. Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid. Innocenti A, Vullo D, Scozzafava A, Supuran CT. Bioorg Med Chem; 2008 Aug 01; 16(15):7424-8. PubMed ID: 18579385 [Abstract] [Full Text] [Related]
19. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB. Güzel O, Innocenti A, Scozzafava A, Salman A, Supuran CT. Bioorg Med Chem; 2009 Jul 15; 17(14):4894-9. PubMed ID: 19539481 [Abstract] [Full Text] [Related]
20. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides. Ozensoy O, Nishimori I, Vullo D, Puccetti L, Scozzafava A, Supuran CT. Bioorg Med Chem; 2005 Nov 15; 13(22):6089-93. PubMed ID: 16006130 [Abstract] [Full Text] [Related] Page: [Next] [New Search]